NASDAQ:CGNXCognex Stock Price, Forecast & News

Cognex's stock was trading at $39.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CGNX shares have increased by 53.4% and is now trading at $60.42. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 4 sell ratings, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cognex.

Cognex is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Cognex.

Cognex Co. (NASDAQ:CGNX) released its quarterly earnings results on Monday, April, 27th. The scientific and technical instruments company reported $0.11 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.08 by $0.03. The scientific and technical instruments company earned $167.20 million during the quarter, compared to analyst estimates of $154.89 million. Cognex had a return on equity of 14.96% and a net margin of 26.58%. The business's revenue was down 3.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.17 earnings per share. View Cognex's earnings history.

Cognex announced a quarterly dividend on Monday, April 27th. Stockholders of record on Friday, May 15th will be paid a dividend of $0.055 per share on Friday, May 29th. This represents a $0.22 annualized dividend and a dividend yield of 0.36%. The ex-dividend date is Thursday, May 14th. View Cognex's dividend history.

Cognex's stock split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly created shares were distributed to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex announced that its Board of Directors has authorized a stock repurchase plan on Monday, October 29th 2018, which authorizes the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 2.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its stock is undervalued.

11 Wall Street analysts have issued 12-month price targets for Cognex's shares. Their forecasts range from $36.00 to $60.00. On average, they anticipate Cognex's stock price to reach $48.90 in the next twelve months. This suggests that the stock has a possible downside of 19.1%. View analysts' price targets for Cognex.

News articles about CGNX stock have been trending negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cognex earned a daily sentiment score of -2.2 on InfoTrie's scale. They also gave news headlines about the scientific and technical instruments company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news about Cognex.

Cognex saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 6,770,000 shares, a drop of 17.6% from the May 31st total of 8,220,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the short-interest ratio is presently 5.1 days. Approximately 4.1% of the shares of the company are short sold. View Cognex's Current Options Chain.

Some companies that are related to Cognex include FLIR Systems (FLIR), National Instruments (NATI), Coherent (COHR), Itron (ITRI), Badger Meter (BMI), OSI Systems (OSIS), Mesa Laboratories (MLAB), FARO Technologies (FARO), MTS Systems (MTSC), Vishay Precision Group (VPG) and Daktronics (DAKT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognex investors own include NVIDIA (NVDA), Alibaba Group (BABA), Arista Networks (ANET), Paypal (PYPL), Micron Technology (MU), Netflix (NFLX), Walt Disney (DIS), Advanced Micro Devices (AMD), Activision Blizzard (ATVI) and Skyworks Solutions (SWKS).

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $60.42.

Cognex has a market capitalization of $10.37 billion and generates $725.63 million in revenue each year. The scientific and technical instruments company earns $203.87 million in net income (profit) each year or $1.16 on an earnings per share basis. Cognex employs 2,267 workers across the globe.

The official website for Cognex is www.cognex.com.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]